Aclaris Therapeutics Aktie
WKN DE: A1412H / ISIN: US00461U1051
|
29.04.2025 13:47:49
|
Aclaris Therapeutics Appoints Jesse Hall As CMO
(RTTNews) - Aclaris Therapeutics, Inc. (ACRS), a clinical-stage biopharmaceutical company, on Tuesday announced the appointment of Jesse Hall as Chief Medical Officer. The transition is effective May 1.
Hall has decades of experience in all phases of drug development. Hall most recently worked as Chief Medical Officer at AltruBio.
On Monday, Aclaris had closed 1.49% higher at $1.36 on the Nasdaq.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Aclaris Therapeutics Incmehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu Aclaris Therapeutics Incmehr Analysen
Aktien in diesem Artikel
| Aclaris Therapeutics Inc | 1,93 | -0,23% |
|